U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Food
  3. Guidance & Regulation (Food and Dietary Supplements)
  4. Guidance Documents & Regulatory Information by Topic (Food and Dietary Supplements)
  5. Infant Formula Guidance Documents & Regulatory Information
  6. Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market
  1. Infant Formula Guidance Documents & Regulatory Information

Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market

Woman looking at a shelf stocked with a variety of Infant Formula.

In March 2023, the FDA released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, which collected observations, described immediate actions, and detailed short-term plans to improve the resiliency of the U.S. infant formula supply. Simultaneously, the FDA partnered with the National Academies of Sciences, Engineering and Medicine (NASEM), as directed by Congress, to further study challenges to the infant formula market in the U.S. in order to inform a long-term strategy.

The Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market outlines long-term actions to improve information-sharing across all stakeholder groups, as well as actions taken since 2023, to help protect the integrity of the infant formula supply chain. The long-term strategy also addresses implementing measures for preventing contamination, incentivizing new infant formula manufacturers to enter the U.S. market, as well as authorities needed to gain better insight into the supply chain and risk for shortages. Through this strategy, we aim to focus efforts on the areas where we have seen the largest impact, illustrate the accomplishments we have achieved in protecting this vital source of nutrition for our most vulnerable population, and highlight where more efforts are needed to continually improve the supply for years to come. The FDA is committed to working with all stakeholders to improve the resiliency of the infant formula supply and to ensure that consumers have the utmost confidence that the infant formula available in the U.S. is safe and nutritious.

Download the Long-Term Strategy (PDF)

Status Update on FDA’s Infant Formula Response Activities

Additional Information

Back to Top